LAUSR

Age-related macular degeneration (AMD) is a degenerative change of the central area of the retina (macula) in people aged 55 years and above and is the leading cause of irreversible sight loss in the developed world. The management of AMD has been transformed over the last decade with the introduction of anti-vascular endothelial growth factor (anti-VEGF) agents. Early treatment of neovascular or ‘wet’ AMD results in better visual outcomes and GPs play a critical role in the early identification and prompt referral of patients with this condition. This article will describe clinical aspects of AMD, prevention, current treatments and management of visual loss.